Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (261-270 of 436) with videos related to

Pageof 44
Sort By:
American Heart Journal|March 31, 2015
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) studyWei Jiang, Stephen H Boyle, Thomas L Ortel, et al.
Journal of Thrombosis and Thrombolysis|September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Archives of Internal Medicine|July 13, 2005
Antithrombotic therapy practices in US hospitals in an era of practice guidelinesVictor F Tapson, Thomas M Hyers, Albert L Waldo, et al.
European Heart Journal. Acute Cardiovascular Care|December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrelMark R Thomas, Stefan K James, Richard C Becker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
Journal of the American Heart Association|January 14, 2018
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) TrialThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary SyndromesThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
American Heart Journal|December 17, 2011
Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trialWei Jiang, Eric J Velazquez, Zainab Samad, et al.
Annals of the Academy of Medicine, Singapore|April 8, 2010
Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal functionMark Y Chan, Richard C Becker, Ling-Ling Sim, et al.
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
Pageof 44

Showing results (261-270 of 436) with videos related to

Sort By:
Pageof 44
American Heart Journal|March 31, 2015
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) studyWei Jiang, Stephen H Boyle, Thomas L Ortel, et al.
Journal of Thrombosis and Thrombolysis|September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Archives of Internal Medicine|July 13, 2005
Antithrombotic therapy practices in US hospitals in an era of practice guidelinesVictor F Tapson, Thomas M Hyers, Albert L Waldo, et al.
European Heart Journal. Acute Cardiovascular Care|December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrelMark R Thomas, Stefan K James, Richard C Becker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
Journal of the American Heart Association|January 14, 2018
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) TrialThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary SyndromesThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
American Heart Journal|December 17, 2011
Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trialWei Jiang, Eric J Velazquez, Zainab Samad, et al.
Annals of the Academy of Medicine, Singapore|April 8, 2010
Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal functionMark Y Chan, Richard C Becker, Ling-Ling Sim, et al.
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
Pageof 44